Absence of MGMT promoter methylation in endometrial cancer
Authors:
- 1 January 2009
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 112 (1) , 224-228
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Targeting Methylguanine-DNA Methyltransferase in the Treatment of NeuroblastomaClinical Cancer Research, 2007
- Microsatellite Instability and Epigenetic Inactivation of MLH1 and Outcome of Patients With Endometrial Carcinomas of the Endometrioid TypeJournal of Clinical Oncology, 2007
- Differential Methylation Hybridization Array of Endometrial Cancers Reveals Two Novel Cancer-Specific Methylation MarkersClinical Cancer Research, 2007
- Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosaGut, 2006
- Methylated Tumor-Specific DNA as a Plasma Biomarker in Patients with GliomaCancer Investigation, 2006
- Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell linesGynecologic Oncology, 2005
- Identification of amyloid β-peptide responsive genes by cDNA microarray technology: Involvement of RTP801 in amyloid β-peptide toxicityExperimental & Molecular Medicine, 2003
- Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents N Engl J Med 343:1350–1354, 2000Neurosurgical Focus, 2001
- A Phase II Gynecologic Oncology Group Trial of Ifosfamide and Mesna in Advanced or Recurrent Adenocarcinoma of the EndometriumGynecologic Oncology, 1996